
iBio IBIO
€ 1.89
-0.9%
Quartalsbericht 2025-Q4
hinzugefügt 10.02.2026
iBio P/E 2011-2026 | IBIO
P/E Jährlich iBio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.3 | -0.303 | -0.00273 | -0.44 | - | -17.9 | -0.742 | -0.541 | -1.9 | -5.14 | -7.01 | -6.7 | -3.98 | -8.21 | -6.86 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.00273 | -17.9 | -4.5 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
Anika Therapeutics
ANIK
|
-4.51 | $ 14.21 | -0.42 % | $ 208 M | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
Aileron Therapeutics
ALRN
|
-0.608 | - | 10.36 % | $ 9.8 M | ||
|
Altimmune
ALT
|
-3.61 | $ 3.35 | -2.62 % | $ 295 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Ascendis Pharma A/S
ASND
|
-19.2 | $ 216.26 | -0.83 % | $ 5 B | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
12.7 | $ 19.12 | -0.57 % | $ 894 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
-1.7 | $ 0.62 | 2.14 % | $ 7.1 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
CRISPR Therapeutics AG
CRSP
|
-7.54 | $ 46.45 | -0.91 % | $ 4.18 B | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.92 | $ 1.4 | -0.36 % | $ 357 M | ||
|
Exelixis
EXEL
|
15 | $ 41.13 | -0.69 % | $ 11.2 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
ChemoCentryx
CCXI
|
-0.0138 | - | - | $ 3.74 B | ||
|
Aytu BioScience
AYTU
|
-1.16 | $ 2.63 | - | $ 16.5 M | ||
|
Fulcrum Therapeutics
FULC
|
-0.0072 | $ 6.64 | -3.63 % | $ 421 K | ||
|
Atreca
BCEL
|
-0.504 | - | -11.76 % | $ 5.79 M | ||
|
BioDelivery Sciences International
BDSI
|
3.63 | - | -4.8 % | $ 255 M | ||
|
Genmab A/S
GMAB
|
33.2 | $ 25.59 | -0.35 % | $ 16.5 B | ||
|
Grifols, S.A.
GRFS
|
31.7 | $ 7.64 | -0.72 % | $ 6.83 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
Halozyme Therapeutics
HALO
|
30.5 | $ 61.68 | -1.88 % | $ 7.39 B | ||
|
Harmony Biosciences Holdings
HRMY
|
10.1 | $ 26.99 | -2.21 % | $ 1.55 B | ||
|
Bellerophon Therapeutics
BLPH
|
-3.96 | - | -74.18 % | $ 955 K | ||
|
ImmuCell Corporation
ICCC
|
-19 | $ 6.43 | 0.31 % | $ 52.5 M | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
Immatics N.V.
IMTX
|
-5.39 | $ 9.32 | -2.0 % | $ 586 M | ||
|
Ionis Pharmaceuticals
IONS
|
-56.3 | $ 69.48 | -1.85 % | $ 11.1 B | ||
|
Innate Pharma S.A.
IPHA
|
-6.87 | $ 1.33 | -2.92 % | $ 235 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
-25.3 | $ 4.29 | -2.94 % | $ 822 M | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M |